Kobo Biotech (BOM:531541) Beta: 0.5579 (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531541 Kobo Biotech Ltd BOM:531541
13 GF Score
Price ₹8.23
View Full Analysis

What is Kobo Biotech Beta?

Kobo Biotech BOM:531541 -1.99% 13 Beta is 0.5579 as of Jul. 30, 2026. GuruFocus rates BOM:531541 with a GF Score™ of 13/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-30), Kobo Biotech's Beta is 0.5579.


Kobo Biotech  (BOM:531541) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Kobo Biotech Beta Related Terms


Kobo Biotech Beta Historical Data

* Premium members only.

The historical data trend for Kobo Biotech's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobo Biotech Beta Chart

Kobo Biotech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.47 0.67 0.13 0.00

Kobo Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Mar25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.42 0.13 0.09 0.00

BOM:531541 vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kobo Biotech's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobo Biotech Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kobo Biotech's Beta distribution charts can be found below:

* The bar in red indicates where Kobo Biotech's Beta falls into.


BOM:531541
13GF Score
Kobo Biotech Ltd BOM:531541
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kobo Biotech Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.5579 mean?
Kobo Biotech (BOM:531541) has a Beta of 0.5579 as of Jul. 30, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Kobo Biotech and its competitors.
Is Kobo Biotech's Beta too high?
Kobo Biotech's current Beta is 0.5579. Overall, Kobo Biotech has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Kobo Biotech's Beta compare to ZTS?
Kobo Biotech's Beta of 0.5579 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Kobo Biotech and its competitors. Kobo Biotech's current Beta is 0.5579. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobo Biotech stock overvalued right now?
Kobo Biotech (BOM:531541) has a current Beta of 0.5579. The current Beta is 0.5579. Kobo Biotech's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Kobo Biotech (BOM:531541), the current Beta is 0.5579 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kobo Biotech Business Description

Address Saki Vihar Road, Unit 104, HYDE Park, Opposite Ansa Industrial Estate, Andheri (East), Mumbai, MH, IND, 400 072
Kobo Biotech Ltd is a pharmaceutical company. Its business comprises the manufacturing and sale of APIs (Active Pharmaceutical Ingredients) based on fermentation technology and Intermediates to pharmaceutical companies.
13GF Score

Get the complete analysis for BOM:531541

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8.23
Price